
  Mrv0541 02231217142D          

 10 10  0  0  1  0            999 V2000
    2.1434    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.8250    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4289    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.8250    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7145    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    1.2375    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.7145    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  3  2  1  1  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  1  0  0  0
  7  9  1  0  0  0  0
  3  9  1  0  0  0  0
  9 10  1  6  0  0  0
M  END
> <DRUGBANK_ID>
DB03862

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
Tetrahydrooxazine

> <CHEMICAL_FORMULA>
C5H11NO4

> <MOLECULAR_WEIGHT>
149.1451

> <EXACT_MASS>
149.068807845

> <IUPAC_NAME>
(4R,5S,6R)-6-(hydroxymethyl)-1,2-oxazinane-4,5-diol

> <IUPAC_TRADITIONAL_NAME>
tetrahydrooxazine

> <INCHI_IDENTIFIER>
InChI=1S/C5H11NO4/c7-2-4-5(9)3(8)1-6-10-4/h3-9H,1-2H2/t3-,4-,5+/m1/s1

> <INCHI_KEY>
InChIKey=KHVCOYGKHDJPBZ-WDCZJNDASA-N

> <SMILES>
OC[C@H]1ONC[C@@H](O)[C@@H]1O

> <JCHEM_ACCEPTOR_COUNT>
5

> <JCHEM_DONOR_COUNT>
4

> <JCHEM_ACIDIC_PKA>
12.94

> <JCHEM_BASIC_PKA>
4.06

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-1.9

> <JCHEM_LOGP>
-2.2

> <ALOGPS_LOGS>
0.72

> <JCHEM_POLARIZABILITY>
13.86

> <JCHEM_POLAR_SURFACE_AREA>
81.95

> <JCHEM_REFRACTIVITY>
42.58

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <ALOGPS_SOLUBILITY>
7.83e+02 g/l __ 

$$$$
